Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03349437 · ClinicalTrials.gov registry record · NA
Vitabreath Pilot in Chronic Obstructive Pulmonary Disease (COPD) Patients
A NA study, sponsored by Philips Respironics.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT03349437 is a NA study that has completed, run by Philips Respironics. The registered enrollment target is 25 participants.
The verdict
NCT03349437, a NA study, has completed, sponsored by Philips Respironics.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
Dyspnea is the most common symptom limiting the ability of COPD patients to perform activities of daily living. Although there has been research involving the benefit of providing Non Invasive Ventilation (NIV) during exercise to increase tolerance overall, there is little research specifically looking at shortening dyspnea recovery times associated with exercise. We hypothesize that providing intermittent non-invasive positive pressure therapy (a form of NIV or PAP) with a handheld device to COPD patients immediately after exertion can relieve their dyspnea, and consequently allow them to be more active. In this study, we are comparing the distance walked as measured by a modified 6-Minute Walk Test (6MWT) of 20 COPD patients using VitaBreath (NIV) device versus Pursed Lip Breathing.
Interventions
- DEVICE Vitabreath Device
- OTHER Pursed Lip Breathing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2017-11-06 |
| Est. Completion | 2018-02-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03349437
The ClinicalTrials.gov registry entry for NCT03349437 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Philips Respironics, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vitabreath Device is the first listed.
NCT03349437 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03349437 about?
NCT03349437 is a clinical study titled "Vitabreath Pilot in Chronic Obstructive Pulmonary Disease (COPD) Patients". Dyspnea is the most common symptom limiting the ability of COPD patients to perform activities of daily living. Although there has been research involving the benefit of providing Non Invasive Ventilation (NIV) during exercise to increase tolerance overall, there is little research specifically look...
What is the current status of trial NCT03349437?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2017-11-06. Estimated completion is 2018-02-20.
What interventions are being tested in trial NCT03349437?
The interventions under investigation include: Vitabreath Device (DEVICE), Pursed Lip Breathing (OTHER).
Who is sponsoring clinical trial NCT03349437?
This trial is sponsored by Philips Respironics, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.